Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Anne Mc Leer"'
Autor:
Julie Mondet, Caroline Lo Presti, Catherine Garrel, Kristina Skaare, Clara Mariette, Sylvain Carras, Sophie Park, Martin Carré, Claude-Eric Bulabois, Lysiane Molina, Rémy Gressin, Anne Thiebaut, Stéphane Courby, Nuria Socoro-Yuste, Patrice Faure, Anne Mc Leer-Florin, Jean-Yves Cahn, Pascal Mossuz
Publikováno v:
Haematologica, Vol 104, Iss 9 (2019)
Externí odkaz:
https://doaj.org/article/ecd9f84b6b5d48778b3217c6dd283003
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Montse Sanchez-Cespedes, Elisabeth Brambilla, Ernest Nadal, Anna Esteve-Codina, Nuria Baixeras, Octavio A. Romero, Eva Pros, Carolina Pereira, Anne Mc Leer-Florin, Juan J. Alburquerque-Bejar, Maria Saigi
Supplementary Fig. 1. A, Western blot showing ectopic and transient expression of the LKB1 protein in the indicated cell lines; Supplementary Fig. 2. A, Profile of JAK2 mutations in NSCLC primary tumors, from the cBioPortal for Cancer Genomics (www.c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e8a2a9795a57efd2a60a96cae1fa14
https://doi.org/10.1158/1078-0432.22469268
https://doi.org/10.1158/1078-0432.22469268
Autor:
Montse Sanchez-Cespedes, Elisabeth Brambilla, Ernest Nadal, Anna Esteve-Codina, Nuria Baixeras, Octavio A. Romero, Eva Pros, Carolina Pereira, Anne Mc Leer-Florin, Juan J. Alburquerque-Bejar, Maria Saigi
Purpose: The blockade of immune checkpoints such as PD-L1 and PD-1 is being exploited therapeutically in several types of malignancies. Here, we aimed to understand the contribution of the genetics of lung cancer to the ability of tumor cells to esca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64397d7e7b930d136f9b06d4b989d376
https://doi.org/10.1158/1078-0432.c.6527190
https://doi.org/10.1158/1078-0432.c.6527190
Autor:
Montse Sanchez-Cespedes, Elisabeth Brambilla, Ernest Nadal, Anna Esteve-Codina, Nuria Baixeras, Octavio A. Romero, Eva Pros, Carolina Pereira, Anne Mc Leer-Florin, Juan J. Alburquerque-Bejar, Maria Saigi
Legends to supplementary figures from 1 to 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7acd57dc99fb6f0220be5a21f97254f8
https://doi.org/10.1158/1078-0432.22469271
https://doi.org/10.1158/1078-0432.22469271
Autor:
Montse Sanchez-Cespedes, Elisabeth Brambilla, Ernest Nadal, Anna Esteve-Codina, Nuria Baixeras, Octavio A. Romero, Eva Pros, Carolina Pereira, Anne Mc Leer-Florin, Juan J. Alburquerque-Bejar, Maria Saigi
Supplementary Table 1. Characteristics of tumors and patients included in the analysis; Supplementary Table 2. List of antibodies and treatments used; Supplementary Table 3. Sequence of primers used for real-time quantitative PCR and size of amplifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38af1581c8cba5ecfe31ce1eb6389587
https://doi.org/10.1158/1078-0432.22469265.v1
https://doi.org/10.1158/1078-0432.22469265.v1
Autor:
Anne Mc Leer, Mathieu Laramas, Séverine Valmary-Degano, Pierre-Yves Brichon, M Chirica, Pierre Chapuis, Amal Fekkar
Publikováno v:
Annales de Pathologie. 41:399-404
Sarcomas are rare tumours that represent less than 1% of all malignant tumours in adults. Liposarcomas are among the most common malignant mesenchymal tumours. They are preferentially located in the limbs and the retroperitoneum. Liposarcomas primari
Autor:
Anne Mc Leer, Denis Moro-Sibilot, Lynette Fernandez-Cuesta, Matthieu Foll, Marie Brevet, Sylvie Lantuéjoul
Publikováno v:
Morphologie. 106:S5-S6
Autor:
Anne Mc Leer, Matthieu Foll, Marie Brevet, Martine Antoine, Silvia Novello, Julie Mondet, Jacques Cadranel, Nicolas Girard, Matteo Giaj Levra, Pierre Demontrond, Clarisse Audigier-Valette, Eric Letouzé, Sylvie Lantuéjoul, Lynnette Fernandez-Cuesta, Denis Moro-Sibilot
Among the different mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors (TKIs) reported in EGFR-mutated lung adenocarcinoma (EGFR-LUAD) patients, histological transformation into small cell carcinoma (SCLC) occurs in 3-14% of resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc73ea5a46acf637b1a5b0c54b25f77
http://hdl.handle.net/2318/1849586
http://hdl.handle.net/2318/1849586
Autor:
Daniel Pissaloux, Anne-Claire Toffart, Saadi Khochbin, Sophie Rousseaux, Camille Emprou, Gilbert Ferretti, Sylvie Lantuejoul, Christine Lefebvre, Séverine Valmary-Degano, Olivier Stephanov, Amal Fekkar, Anne Mc Leer
Publikováno v:
Lung Cancer
Lung Cancer, Elsevier, 2021, ⟨10.1016/j.lungcan.2021.06.008⟩
Lung Cancer, 2021, ⟨10.1016/j.lungcan.2021.06.008⟩
Lung Cancer, Elsevier, 2021, ⟨10.1016/j.lungcan.2021.06.008⟩
Lung Cancer, 2021, ⟨10.1016/j.lungcan.2021.06.008⟩
International audience; NUT carcinoma (NC), formerly known as NUT midline carcinoma, is a rare and very aggressive cancer. It is genetically defined by the presence of acquired chromosomal rearrangement of the NUTM1 (NUclear protein in Testis Midline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ef324ceea733315647cfc01e6844e8c
https://hal.archives-ouvertes.fr/hal-03364416/file/Fekkar_2021.pdf
https://hal.archives-ouvertes.fr/hal-03364416/file/Fekkar_2021.pdf